Covid-19: As lab execs sell shares worth millions, questions arise

- Several Moderna officials have sold shares worth more than $100 million in recent months
- Executives at Pfizer and Moderna were operating under a rule put in place by the SEC in 2000 to allow company employees to sell shares without facing insider-trading charges